Evidence map›Paper›PMID 36812447›Full record

ArticleJCO global oncology2023

ASCO's Leadership Development Program: Focusing on the Next Generation of Leaders in Asia Pacific.

Roselle B de Guzman, Melvin L K Chua, David Goldstein, Soe Aung, Vanessa Eaton, Keunchil Park

Abstract read
In one paragraph

Article in JCO global oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Roselle B de GuzmanManila Central University-FDT Medical Foundation Hospital, Caloocan City, Philippines.ORCID 0000-0002-1930-9935
Melvin L K ChuaDepartment of Head and Neck and Thoracic Cancers, Division of Radiation Oncology, National Cancer Centre Singapore, Singapore.ORCID 0000-0002-1648-1473
David GoldsteinNelune Cancer Centre, Prince of Wales Hospital, Randwick, Australia.
Soe AungMyanmar Oncology Society, University of Medicine 1, Yangon, Myanmar.ORCID 0000-0003-1003-0791
Vanessa EatonAmerican Society of Clinical Oncology, Alexandria, VA.
Keunchil ParkSamsung Medical Center, Seoul, South Korea.ORCID 0000-0002-4846-7449

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe demand for high-quality and more comprehensive oncology care will continue to rise globally. Effective leadership is particularly important.

methodsThe evolving endeavor of ASCO to reach out globally has covered the development of the next-generation leaders from Asia Pacific. Through the Leadership Development Program, the untapped talent of the region and the future leaders in oncology will gain the knowledge and skill sets, which prepares them to navigate the complex dynamics of oncology health care.

resultsThe region is the largest and the most populous with more than 60% of the world's population. It has 50% of cancer cases and is estimated to account for 58% of cancer deaths worldwide. The demand for high-quality and more comprehensive oncology care will continue to rise in the years to come. This growth will intensify the need for capable leaders. Leadership styles and behaviors are different. These are shaped within the context of cultural and philosophical views and beliefs. The pan-Asian interdisciplinary group of young leaders are expected to gain knowledge and skillsets through the Leadership Development Program. They will learn to work on strategic projects within a team and gain knowledge about advocacy. Communication and presentation skills and conflict management are also important components of the program. Through learning culturally relevant skills, participants can effectively collaborate with others, build relationships, and lead within their own institutions and societies and within ASCO.

conclusionInstitutions and organizations need to have a deeper and more sustained focus on leadership development. Successfully addressing the challenges on leadership development in Asia Pacific is important.

Indexed as

LeadershipNeoplasmsAsiaDelivery of Health CareHumansMedical Oncology

Identifiers

PMID36812447
PMCPMC10166472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.